0.3293

3.99% -0.0137

After Hours: .34 0.0107 +3.25%

Senti Biosciences Holdings Inc (SNTI)

Overview News Price History Financials Discussions Forecast

Senti Biosciences Holdings Inc stock is traded at $0.3293, with a volume of 919.57K. It is down -3.99% in the last 24 hours and down -15.76% over the past month. Senti Biosciences Holdings Inc, formerly known as Senti Biosciences Inc, is a clinical-stage biotechnology company developing cell and gene therapies using its gene circuit platform for patients with incurable diseases. Its gene circuits, created from proprietary DNA sequences, are designed to reprogram cells to sense, compute, and respond to cellular environments. Its product candidates are to kill cancer cells, spare healthy cells, increase specificity, and control drug expression. Its candidate, SENTI-202, is a logic-gated off-the-shelf CAR-NK cell therapy for blood cancers, currently in a Phase 1 clinical trial in the United States and Australia for relapsed or refractory hematological malignancies, including Acute Myeloid Leukemia (AML).

Previous Close:

$0.343

Open:

$0.32

24h Volume:

919.57K

Relative Volume:

2.39

Market Cap:

$10.26M

Revenue:

$38,000

Net Income/Loss:

$-51.55M

P/E Ratio:

-0.1714

EPS:

-1.9207

Net Cash Flow:

$-37.07M

1W Performance:

+2.91%

1M Performance:

-15.76%

6M Performance:

-62.63%

1Y Performance:

-76.48%

1-Day Range:

$0.3051

$0.337

1-Week Range:

$0.3051

$0.37

52-Week Range:

$0.29

$2.88

Senti Biosciences Holdings Inc Stock (SNTI) Company Profile

Name

Senti Biosciences Holdings Inc

Sector

Healthcare (1067)

Industry

Biotechnology (595)

Phone

(650) 239-2030

Address

2 CORPORATE DRIVE, FIRST FLOOR, SOUTH SAN FRANCISCO

Employee

Twitter

Next Earnings Date

2026-11-12

Latest SEC Filings

SNTI's Discussions on Twitter

Compare SNTI vs VRTX, REGN, MRNA, ARGX, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SNTI Senti Biosciences Holdings Inc	0.3293	10.26M	38,000	-51.55M	-37.07M	-1.9207
VRTX Vertex Pharmaceuticals Inc	526.19	133.37B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	788.04	81.13B	14.92B	4.42B	3.79B	41.04
MRNA Moderna Inc	198.88	79.40B	2.23B	-3.19B	-1.60B	-8.1462
ARGX Argen X Se Adr	959.49	60.03B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	204.97	43.93B	742.00K	-1.37B	-1.07B	-7.0731

Senti Biosciences Holdings Inc Stock (SNTI) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-14-25	Initiated	H.C. Wainwright	Buy
Jun-06-25	Initiated	Laidlaw	Buy
Oct-07-22	Initiated	Morgan Stanley	Equal-Weight

Senti Biosciences Holdings Inc Stock (SNTI) Latest News

Sep 25, 2026

Senti Biosciences Holdings, Inc. SEC Filing (Sep 25, 2026) - Stock Titan

Sep 25, 2026

Sep 24, 2026

Senti Biosciences registers resale of 2.55 crore shares from notes - scanx.trade

Sep 24, 2026

Form 4 Senti Biosciences Holdings Inc For: 24 September By Investing.com - Investing.com India

Sep 24, 2026

12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga

Sep 24, 2026

Senti Biosciences Announces Board and Committee Leadership Change - tipranks.com

Sep 24, 2026

No cash at closing for Senti Biosciences (NASDAQ: SNTI) shareholders; future payments hinge on milestones. - Stock Titan

Sep 24, 2026

No cash at closing in Senti Biosciences (NASDAQ: SNTI)'s proposed merger; payments depend on milestones. - Stock Titan

Sep 24, 2026

Sep 23, 2026

12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga

Sep 23, 2026

Sep 22, 2026

Form S-3/A SENTI BIOSCIENCES HOLDINGS For: 22 September By Investing.com - Investing.com Canada

Sep 22, 2026

Senti Biosciences (SNTI) refreshes auditor sign-off on shelf registration - Stock Titan

Sep 22, 2026

Sep 18, 2026

Senti Biosciences Inc (NASDAQ: SNTI) Share Price, SNTI Stock News, SNTI Share Price & Updates - kalkine.com.au

Sep 18, 2026

Sep 16, 2026

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Sep 16, 2026

Sep 14, 2026

Senti Biosciences (NASDAQ: SNTI) Secures $2.5 Million Stock Purchase at Nasdaq Minimum Price Following Merger - Kalkine Media

Sep 14, 2026

Sep 11, 2026

Major backer lines up $2.5M for Senti Biosciences (NASDAQ: SNTI) if merger closes - Stock Titan

Sep 11, 2026

Sep 10, 2026

Convertible notes could hand one investor control of Senti (NASDAQ: SNTI) - Stock Titan

Sep 10, 2026

Sep 04, 2026